Your guide to miniaturized immunoassays for biotherapeutics
25 March 2021

Building on advances in microfluidics, next-generation immunoassays offer unparalleled capability in automation and miniaturization, generating robust and reproducible results for faster decision-making.

In this eBook, discover the advantages of automated, miniaturized immunoassays across the drug development pathway, from pre-clinical to bioprocessing. Learn about challenges and trends in immunoassay technology and how automated, miniaturized immunoassays can help you maximize productivity across a range of biopharmaceutical applications, including:

  • Research and clinical development
  • Insulin quantification
  • Anti-drug antibody studies
  • In-solution affinity determination
  • Vaccine development and production